Neutrophil apoptosis in patients with β-thalassemia major

Pediatric Hematology and Oncology

Volumn 20, Issue 3, 2003, Pages 237-243

  Ören, Hale ^a   Şahin, Bariş ^a   Irken, Gülersu ^a   Ateş, Halil ^a   Duman, Murat ^a   Yilmaz, Şebnem ^a   Türker, Meral ^a   Atabay, Berna ^b   Yaprak, Işin ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Department of Pediatrics   (Turkey)

Author keywords

Apoptosis; Desferrioxamine; Ferritin; Neutrophil; thalassemia

Indexed keywords

DEFEROXAMINE; FERRITIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5;

ADOLESCENT; APOPTOSIS; ARTICLE; BETA THALASSEMIA MAJOR; CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; INFECTION RATE; INFECTION SENSITIVITY; MALE; NEUTROPHIL; STATISTICAL SIGNIFICANCE; THALASSEMIA;

EID: 0346817414     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/713842280     Document Type: Article

References (34)

1. Weatherall DJ, Clegg JB. The Thalassemia Syndromes, ed 2. Oxford, UK: Blackwell Scientific; 1981.
2. WHO. Community control of hereditary anemias: memorandum from a WHO meeting. Bull WHO. 1983;61:63.
3. Baysal E, Carver MF. The beta-and delta-thalassemia repository, ed 8. Hemoglobin. 1995;19:213-216.
4. Aksoy M, Kutlar A, Kutlar F, Dinçol G, Erdem S, Bastesbihçi S. Survey on hemoglobin variants, beta thalassemia, glucose-6-phosphate dehydrogenase deficiency, and haptoglobin types in Turks from western thrace. J Med Genet. 1985;22:288-290.
5. Fessas P. Inclusions of hemoglobin in erytroblasts and erythrocytes of thalassemia. Blood. 1963;21:21.
6. Bargellesi A, Pontremoli S, Menini C, Conconi F. Excess of alpha globin synthesis in homozygous beta-thalassemia and its removal from the red blood cell cytoplasm. Eur J Biochem. 1968;3:364-368.
7. Yuan J, Angelucci E, Lucarelli G, et al. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia). Blood. 1993;82:374-377.
8. Centis F, Tabellini L, Lucarelli G, et al. The imṕortance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood. 2000;96:3624-3629.
9. Orkin SH, Nathan DG. The thalassemias. In: Orkin SH, Nathan DG, eds. Hematology of Infancy and Childhood, ed 5. Philadelphia: WB Saunders; 1998:811-816.
10. Bassaris HP, Lianou PE, Skoutelis AT, Papavassiliou JT, Phair JP. Defective adherence of polymorphonuclear leukocytes to nylon induced by thalassemic serum. J Infect Dis. 1982;146:52-55.
11. Khan AJ, Lee CK, Wolff JA, Chang H, Khan P, Evans HE. Defects of neutrophil chemotaxis and random migration in thalassemia major. Pediatrics. 1977;60:349-351.
12. Skoutelis AT, Lianou E, Papavassiliou T, Karamerou A, Politi K, Bassaris HP. Defective phagocytic and bactericidal function of polymorphonuclear leucocytes in patients with beta-thalassaemia major. J Infect. 1984;8:118-122.
13. Cantinieaux B, Hariga C, Ferster A, De Maertelaere E, Toppet M, Fondu P. Neutrophil dysfunctions in thalassaemia major: the role of cell iron overload. Eur J Haematol. 1987;39:28-34.
14. Kütükçüler N, Kutlu O, Nisli G, Öztop S, Çetingul N, Çaglayan S. Assessment of neutrophil chemotaxis and random migration in children with thalassemia major. Pediatr Hematol Oncol. 1996;13:239-245.
15. Cantinieaux B, Janssens A, Boelaert JR, et al. Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis. J Lab Clin Med. 1999;133:353-361.
16. Sofroniadou K, Drossou M, Foundoulaki L, Konstantopoulos K, Kyriakoy D, Zervas J. Acute bone marrow aplasia associated with intravenous administration of deferoxamine (desferrioxamine). Drug Safety. 1990;5:152-154.
17. Olivieri NF, Buncic JR, Chew E, et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med. 1986;314:869-873.
18. Koren G, Bentur Y, Strong D, et al. Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child. 1989;143:1077-1080.
19. Olivieri NF, Koren G, Harris J, et al. Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992;14:48-56.
20. Hoffbrand AV, Geneshaguru K, Hooton JML, Tattersall MHN. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol 1976;33:517-526.
21. Tomoyasu S, Nakamaki T, Suzuki K, Tsuruoka N. Growth inhibition and promotion of differentiation induction in cultured leukemia cell lines by deferoxamine. Nippon Ketsueki Gakkai Zasshi. 1987;50:568-574.
22. Polson RJ, Jenkins R, Lombard M, et al. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology. 1990;71:176-181.
23. Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K. Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett. 1994;350:139-142.
24. Kyriakou D, Eliopoulos AG, Papadakis A, Alexandrakis M, Eliopoulos GD. Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine. Eur J Haematol. 1998;60:21-27.
25. Boyum A. Seperation of leukocytes from blood and bone marrow. Scand J Clin Invest Suppl. 1968;97:7.
26. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
27. Naito M, Nagashima K, Mashima T, Tsuruo T. Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. Blood. 1997;89:2060-2066.
28. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39-51.
29. Homburg CHE, de Haas M, von dem Borne AEGK, Verhoeven AJ, Reutelingsperger CPM, Roos D. Human neutrophils lose their surface FcγRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 1995;85:532-540.
30. Hann HW, Sthalhut MW, Lee S, London WT, Hann RS. Effects of isoferritins on human granulocytes. Cancer. 1989;63:2492-2496.
31. Cantinieaux B, Hariga C, Ferster A, Toppet M, Fondu P. Desferrioxamine improves neutrophil phagocytosis in thalassemia major. Am J Hematol. 1990;35:13-17.
32. Binet JL, Mentz F, Merle-Beral H. Apoptosis in blood diseases. Review new data. Hematol Cell Ther. 1996;38:253-264.
33. Ginis I, Faller DV. Integrin-mediated adhesion to activated endothelium protects human neutrophils from apoptosis. Blood. 1995;86(Suppl 1):501.
34. Butthep P, Bunyaratvej A, Funahara Y, et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J Trop Med Public Health. 1997;28 (Suppl 3):141-148.